News / Africa

AIDS: Delaying Treatment Has Health and Financial Costs

Multimedia

Audio
Joe DeCapua

A new study says delaying treatment for people infected with HIV can have long-term health and financial consequences.  The findings add to the debate over when anti-retroviral treatment should begin.

A growing body of research says starting HIV-infected people on drug treatment sooner is better for the patient.  Initially, the drugs were given when a person’s CD4 immune cell count fell to 200 or below.  By that time, the patent could have full-blown AIDS.

Now the general recommendation is to start treatment when CD4 counts reach 350 – before the immune system collapses.  Despite that recommendation, many people are receiving delayed treatment.

Looking at the evidence

Dr. Kelly Gebo – a Johns Hopkins University professor of Epidemiology – is the senior author of the study.  Gebo and her team reviewed the medical records of more than 8,000 patients in the United States between 2000 and 2007.

“So, we actually didn’t look at when to start treatment.  We looked at when people presented for care.  And we found that unfortunately nearly half of people – 43 percent of people – were presenting late for care.  And those people cost more over the long run,” she says.

Gebo says the study did not look at why treatment was delayed, but the findings did give a few hints.

“One of the things anecdotally that we do tend to find,” she says, “is that people are hospitalized for a severe opportunistic illness and then sort of follow-up for outpatient care.  They may have known they were HIV infected for a long period of time and not come for care just because they didn’t feel bad or everything was going well.  And then when something catastrophic happens is when they start embarking on care.”

CD4 countdown

Once a person is infected with HIV, unless treatment is given, there’s usually a long but steady decline in CD4 cells.  So, symptoms of the disease may not appear right away.

Gebo says, “Most people have a CD4 count between 800 and 1200.  So we say an average of a thousand.  And in HIV when we didn’t have antiretrovirals the average CD4 count fell by about a hundred cells per year.  So we said it was about eight years from infection to development of AIDS.  And in general, it was about a 10-year life expectancy.  Now, with antiretrovirals, the whole ballgame has changed.”

Earlier treatment with antiretrovirals gives a person a much better chance of avoiding other illnesses besides full-blown AIDS.

“So clinically we know that people do better,” she says, “They have fewer opportunistic illnesses.  They seem to have fewer non-traditionally AIDS-related events.  So, cardiovascular disease, malignancies, end stage liver disease, end stage renal disease – all appear to be higher in HIV-infected patients.  So treatment with antiretrovirals has been shown to slow the progression of some of those.”

And then there are the medical costs

The average difference - between those receiving treatment early and those who didn’t - ranged from about $27,000 to more than $60,000 over the first seven to eight years.  Costs are higher for the so-called late presenters because they are often sicker than early presenters.

“We did look at direct medical costs.  And in the direct medical costs, it was certainly cheaper with treating people with antiretrovirals, even given the cost of 10 to 12 thousand dollars a year for antiretrovirals when you look at the reduction in hospitalizations, other medications used and some of the other outpatient utilization and laboratories that we evaluate in our study,” she says.

And earlier treatment allows people to be more productive longer.

While the study was not done in a developing country, the findings may provide guidance.  Some countries in sub-Saharan Africa, for example, are debating whether to start antiretroviral treatment earlier.  However, that means spending more on HIV/AIDS at a time when many economies are still reeling from the global recession.

More details on the study can be found in the December issue of the journal Medical Care.

You May Like

Anti-Terror Drills Highlight China’s Push Into Central Asia

China, Russia, several central Asian countries wrap up massive anti terrorism military drills in Inner Mongolia More

Erdogan’s First Step: Secure More Power in New Role in Turkey

Erdogan was sworn in as Turkey's first popularly elected president on Thursday; he picked former foreign minister Ahmet Davutoglu as PM More

Pakistan Army Fails to Break Political Deadlock

PM Sharif claims he didn't ask army to defuse crisis; military rejects claim More

This forum has been closed.
Comments
     
There are no comments in this forum. Be first and add one

Featured Videos

Your JavaScript is turned off or you have an old version of Adobe's Flash Player. Get the latest Flash player.
Ukraine Battles Pro-Russia Rebel Assaulti
X
Daniel Schearf
August 29, 2014 9:30 PM
After NATO concluded an emergency meeting to discuss the crisis in eastern Ukraine, the country is struggling to contain heavy fighting near the strategic port of Mariupol, on the Azov Sea. Separatist rebels are trying to capture the city, allegedly with Russian military help, and Ukraine's defense forces are digging in. VOA's Daniel Schearf spoke with analysts about what lies ahead for Ukraine.
Video

Video Ukraine Battles Pro-Russia Rebel Assault

After NATO concluded an emergency meeting to discuss the crisis in eastern Ukraine, the country is struggling to contain heavy fighting near the strategic port of Mariupol, on the Azov Sea. Separatist rebels are trying to capture the city, allegedly with Russian military help, and Ukraine's defense forces are digging in. VOA's Daniel Schearf spoke with analysts about what lies ahead for Ukraine.
Video

Video Growing Business Offers Paint with a Twist of Wine

Two New Orleans area women started a small business seven years ago with one thing in mind: to help their neighbors relieve the stress of coping with a hurricane's aftermath. Today their business, which pairs painting and a little bit of wine, has become one of the fastest growing franchises across the U.S. VOA’s June Soh met the entrepreneurs at their newest franchise location in the Washington suburbs.
Video

Video Ebola Vaccine Trials To Begin Next Week

The National Institutes of Health says it is launching early stage trials of a vaccine to prevent the Ebola virus, which has infected or killed thousands of people across West Africa. The World Health Organization says Ebola could infect more than 20,000 people across the region by the time the outbreak is over. The epidemic has health experts and governments scrambling to prevent more people from becoming infected. Zlatica Hoke has more.
Video

Video Asian Bacteria Threatens Florida Orange Trees

Florida's citrus fruit industry is facing a serious threat from a bacteria carried by the Asian insect called psyllid. The widespread infestation again highlights the danger of transferring non-native species to American soil. VOA’s George Putic reports.
Video

Video Aging Will Reduce Economic Growth Worldwide in Coming Decades

The world is getting older, fast. And as more people retire each year, fewer working-age people will be there to replace them. Bond rating agency Moody’s says that will lead to a decline in household savings; reducing global investments - which in turn, will lead to slower economic growth around the world. But experts say it’s not too late to mitigate the economic impact of the world’s aging populations. Mil Arcega has more.
Video

Video Is West Doing Enough to Tackle Islamic State?

U.S. President Barack Obama has ruled out sending ground troops to Iraq to fight militants of the so-called Islamic State, or ISIS, despite officials in Washington describing the extremist group as the biggest threat the United States has faced in years. Henry Ridgwell reports from London on the growing uncertainty over whether the West’s response to ISIS will be enough to defeat the terrorist threat.
Video

Video Coalition to Fight Islamic State Could Reward Assad

The United States along with European and Mideast allies are considering a broader assault against Islamic State fighters who have spread from Syria into Iraq and risk further destabilizing an already troubled region. But as VOA State Department Correspondent Scott Stearns reports, confronting those militants could end up helping the embattled Syrian President Bashar al-Assad.
Video

Video Made in America Socks Get Toehold in Online Fashion Market

Three young entrepreneurs are hoping to revolutionize the high-end sock industry by introducing all-American creations of their own. And they’re doing most of it the old-fashioned way. VOA’s Julie Taboh recently caught up with them to learn what goes into making their one-of-a-kind socks.
Video

Video Americans, Ex-Pats Send Relief Supplies to West Africa

Health organizations from around the world are sending supplies and specialists to the West African countries that are dealing with the worst Ebola outbreak in history. On a smaller scale, ordinary Americans and African expatriates living in the United States are doing the same. VOA's Carol Pearson reports.
Video

Video America's Most Popular Artworks Displayed in Public Places

Public places in cities across America were turned into open-air art galleries in August. Pictures of the nation’s most popular artworks were displayed on billboards, bus shelters, subway platforms and more. The idea behind “Art Everywhere,” a collaborative campaign by five major museums is to allow more people to enjoy art and learn about the country’s culture and history. Faiza Elmasry has more.
Video

Video Chinese Doctors Use 3-D Spinal Implant

A Chinese boy suffering from a debilitating bone disease has become the first patient with a part of his spine created in a three-dimensional printer. Doctors say he will soon regain normal mobility. VOA’s George Putic reports.
Video

Video India’s Leprosy Battle Stymied by Continuing Stigma

Medical advancements in the treatment of leprosy have greatly diminished its impact around the world, largely eliminating the disease from most countries. India made great strides in combating leprosy, but still accounts for a majority of the world’s new cases each year, and the number of newly infected Indians is rising - more than 130,000 recorded last year. Doctors there say the problem has more to do with society than science. Shaikh Azizur Rahman reports from Kolkata.

AppleAndroid